Innovative Genomics Institute—a partnership between University of California, San Francisco and the University of California, Berkeley—has released their findings on a new gene-editing method that holds the potential to advance treatment against cancer. This new immunotherapy process involves using electric fields rather than viruses to splice into white blood cells to deliver gene-editing tools and modified genetic material. Not only is it efficient, it’s far faster than previous methods. Right now, the findings are being processed and tested in other labs as a next step. Read more about the study, which was published in Nature, at the New York Times.